Free Trial

Obesity Drug Boom, Split Make This Stock a Heavy Bargain

unlock icon  Upgrade Now

This premium article is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

Should You Invest $1,000 in Novo Nordisk A/S Right Now?

Before you consider Novo Nordisk A/S, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novo Nordisk A/S wasn't on the list.

While Novo Nordisk A/S currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Novo Nordisk A/S (NVO)
4.4382 of 5 stars
$58.64-1.6%1.40%16.11Moderate Buy$77.50
Eli Lilly and Company (LLY)
4.9928 of 5 stars
$854.401.0%0.70%55.84Moderate Buy$948.56
Walmart (WMT)
4.5856 of 5 stars
$101.72-1.1%0.92%38.24Moderate Buy$112.38
Mondelez International (MDLZ)
4.7854 of 5 stars
$61.00-1.1%3.28%22.34Moderate Buy$71.55
Nestle (NSRGY)
1.3731 of 5 stars
$92.58-0.9%2.56%N/AHold$91.00
Compare These Stocks  Add These Stocks to My Watchlist 

Featured Articles and Offers

Related Videos

Markets Are Sliding: Where to Find Opportunity
Top Trades: Massive Gains and Costly Mistakes to Avoid

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines